Tivozanib hydrate是替沃扎尼的水合物形式，为口服有效的血管内皮生长因子受体抑制剂，具有显著抗肿瘤活性。

/

-25~-15℃避光保存，有效期3年。

[1] Nakamura K, Taguchi E, Miura T, Yamamoto A, Takahashi K, Bichat F, Guilbaud N, Hasegawa K, Kubo K, Fujiwara Y, Suzuki R, Kubo K, Shibuya M, Isae T. KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties. Cancer Res. 2006 Sep 15;66(18):9134-42. doi: 10.1158/0008-5472.CAN-05-4290. PMID: 16982756.